Impact of Fed Interest Rate Cuts on Stocks

Interest rate cuts from the Federal Reserve tend to uplift stock prices across the board, but some stocks, particularly those in real estate and finance, seem to gain more than others. Companies like Home Depot, Bristol Myers Squibb, and Capital One saw notable increases of about 11%, 8.5%, and 5%, respectively, in August as speculation grew around potential rate cuts in September. Market expectations have soared, with tools like the CME FedWatch showing over an 85% likelihood of cuts. The Fed hasn’t adjusted rates since their last three cuts late last year.

Jerome Powell has indicated that current economic conditions may warrant changes to their policy. Under pressure from President Trump to lower borrowing costs, Powell acknowledged inflation risks from tariffs but expressed more concern over a slowing labor market. Central bankers have been deliberating how to balance steady pricing and the goal of maximum employment, which influences their decisions.

Following Powell’s remarks, the stock market experienced gains compared to the previous week. The S&P 500 has remained relatively stable this week. Speculation around the Fed’s September meeting could lead to interest rate adjustments, though it remains uncertain if the bond market will respond positively. Typically, lower interest rates from the Fed lead to declining bond yields, which is significant as mortgage rates often closely follow the 10-year Treasury yield, which has seen a slight decrease recently.

Looking ahead, the overall increase amid expected inflation signals around 3.5% for 10-year yields. Yet, consumer debt costs have remained around 4.23%. It’s still lost in ambiguity how rate reduction cycles will play out, but there are several key stocks to consider: Home Depot, Bristol Myers, and Capital One among them.

Home Depot stands to gain significantly from lower borrowing costs. A decline in mortgage interest rates below 6% combined with a housing market rebound could bolster demand for their products. New homeowners often start their journeys with renovations, benefiting Home Depot directly. We initially invested in Home Depot based on this potential, although the anticipated response hasn’t fully materialized, largely due to challenges in the bond market. Nonetheless, we remain optimistic about the stock, with a focus on their professional business, which tends to be less volatile than the DIY sector.

DuPont could also benefit if the housing market improves. Their Water and Conservation Reporting segment provides materials connected to home construction. However, it’s uncertain how much of DuPont’s revenue is tied to these products. This segment signifies 44% of their total revenue forecast for 2024. An improved housing market along with lower rates could enhance demand for DuPont’s offerings.

As for Capital One, a decline in borrowing costs might encourage consumers to spend more, leading to a potential increase in interest-based revenues. The integration with Discover, which they acquired in May, could further solidify their market position. Discover’s dual role as a major card issuer and payment network adds competitive strength for Capital One.

Wells Fargo could benefit from higher loan activity as borrowing costs drop. Management has been working on diversifying their revenue streams, particularly through fee-based services such as investment banking. Recent regulatory relief has also lifted some restrictions, potentially boosting overall sales. Goldman Sachs looks poised to reap rewards as well; their investment banking segment often sees a rise in activity like mergers and initial public offerings when economic uncertainties decrease, allowing them to earn from advisory and underwriting fees.

Dividend-paying stocks, like Bristol Myers—a company with an annual yield around 5.3%—are likely to be appealing in this low-rate environment. Similarly, Starbucks, yielding about 2.8%, can attract investor interest. Although both companies don’t rely solely on dividends for their appeal, Bristol Myers is expecting promising outcomes from trials for its new schizophrenia treatment, Cobenfy. Meanwhile, Starbucks is undergoing a turnaround strategy under CEO Brian Niccol, which adds to their potential.

For investors, especially those in groups like the CNBC Investment Club, it’s important to stay informed about trading strategies and potential stock movements, with specific timelines in place to ensure updates are communicated carefully.